Pediatric lymphomas and histiocytic disorders of childhood
- PMID: 25435117
- PMCID: PMC4250829
- DOI: 10.1016/j.pcl.2014.09.010
Pediatric lymphomas and histiocytic disorders of childhood
Abstract
Although there have been dramatic improvements in the treatment of children with non-hodgkin lymphoma, hodgkin lymphoma and histiocytic disorders over the past 3 decades, many still relapse or are refractory to primary therapy. In addition, late effects such as 2nd malignancies, cardiomyopathy and infertility remain a major concern. Thus, this review focuses on the current state of the science and, in particular, novel treatment strategies that are aimed at improving outcomes for all pediatric patients with lymphoma and histiocytic disorders while reducing treatment related morbidity.
Keywords: Anaplastic large cell lymphoma (ALCL); Burkitt lymphoma (BL); Diffuse large B-cell lymphoma (DLBCL); Hodgkin lymphoma (HL); Juvenile xanthoganuloma (JXG); Langerhans cell histiocytosis (LCH); Posttransplant lymphoproliferative disease (PTLD); Rosai-Dorfman disease (RDD).
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Cancer. 1995;75(8):2186–95. - PubMed
-
- Sandlund JT, Downing JR, Crist WM. Non-Hodgkin’s lymphoma in childhood. N Engl J Med. 1996;334(19):1238–48. - PubMed
-
- Swerdlow SH, Webber SA, Chadburn A, et al. Post transplant lymphoproliferative disorders. International Agency for Research on Cancer; 2008. pp. 342–9.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous